Dermal peptide delivery using colloidal carrier systems

Skin Pharmacology and Physiology

Volumn 21, Issue 1, 2008, Pages 3-9

  Goebel, Alexandra ^a   Neubert, Reinhard H H ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Biopharmaceutics; Colloidal carrier; Dermal drug delivery; Microemulsion; Peptide; Solubilization

Indexed keywords

CYCLOSPORIN A; DESMOPRESSIN; DRUG CARRIER;

DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG SOLUBILITY; DRUG STRUCTURE; ELECTROPORATION; GRANULOMATOUS HEPATITIS; HUMAN; KIDNEY TUBULE DISORDER; MICROEMULSION; MOLECULAR BIOLOGY; PRIORITY JOURNAL; REVIEW; SKIN PERMEABILITY; STRATUM CORNEUM;

ADMINISTRATION, CUTANEOUS; ANIMALS; COLLOIDS; DERMIS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EMULSIONS; HUMANS; PEPTIDES; SKIN ABSORPTION;

EID: 38349115958     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109082     Document Type: Review

References (54)

1. Lee VHL: Changing needs in drug delivery in the era of peptide and protein drugs. Adv Parent Sci 1990;4:1-56.
2. Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M: Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Organ 1999;77:789-800.
3. Wertz PW, Downing DT: Stratum corneum: biological and biochemical considerations; in Hadgraft J, Guy RH (eds): Transdermal Drug Delivery: Development Issues and Research Initiatives. New York, Dekker, 1989, pp 1-22.
4. Kalia YN, Naik A, Garrison J, Guy RH: Iontophoretic drug delivery. Adv Drug Deliv Rev 2004;56:619-658.
5. Schuetz YB, Carrupt PA, Naik A, Guy RH, Kalia YN: Structure-permeation relationships for the non-invasive transdermal delivery of cationic peptides by iontophoresis. Eur J Pharm Sci 2006;29:53-59.
6. Prausnitz MR, Mitragotri S, Langer R: Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov 2004;3:115-124.
7. Ledger PW: Skin biological issues in electrically enhanced transdermal delivery. Adv Drug Deliv Rev 1992;9:289-307.
8. Pillai O, Panchagnula R: Transdermal iontophoresis of insulin. VI. Influence of pretreatment with fatty acids on permeation across rat skin. Skin Pharmacol Physiol 2004;17:289-297.
9. Boinpally RR, Zhou SL, Devraj G, Anne PK, Poondru S, Jasti BR: Iontophoresis of lecithin vesicles of cyclosporin A. Int J Pharm 2004;274:185-190.
10. Sen A, Daly ME, Hui SW: Transdermal insulin delivery using lipid enhanced electroporation. Biochim Biophys Acta Biomembranes 2002;1564:5-8.
11. Gill HS, Prausnitz MR: Coated microneedles for transdermal delivery. J Control Release 2007;117:227-237.
12. Cormier M, Johnson B, Ameri M, et al: Transdermal delivery of desmopressin using a coated microneedle array patch system. J Control Release 2004;97:503-511.
13. Prausnitz MR: Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 2004;56:581-587.
14. Ito Y, Hagiwara E, Saeki A, Sugioka N, Takada K: Feasibility of microneedles for percutaneous absorption of insulin. Eur J Pharm Sci 2006;29:82-88.
15. Smith NB, Lee S, Maione E, Roy RB, McElligott S, Shung KK: Ultrasound-mediated transdermal transport of insulin in vitro through human skin using novel transducer designs. Ultrasound Med Biol 2003;29:311-317.
16. De Gennes PG, Taupin C: Microemulsions and the flexibility of oil/water interfaces. J Phys Chem 1982;86:2294-2304.
17. Langevin D: Micelles and microemulsions. Annu Rev Phys Chem 1992;43:341-369.
18. Moulik SP, Paul BK: Structure, dynamics and transport properties of microemulsions. Adv Colloid Interface Sci 1998;78:99-195.
19. Danielsson I, Lindman B: The definition of microemulsion. Colloids Surfaces 1981;3:391-392.
20. Eccleston GM: Microemulsions; in Swarbrick J, Boylan JC (eds): Encyclopedia of Pharmaceutical Technology. New York, Dekker, 1994, vol 9.
21. Schulman JH, Stoeckenius W, Prince LM: Mechanism of formation and structure of microemulsions by electron microscopy. J Phys Chem 1959;63:1677-1680.
22. Kreilgaard M: Influence of microemulsions on cutaneous drug delivery. Adv Drug Deliv Rev 2002;54:S77-S98.
23. Attwood D: Microemulsions; in Kreuter J (ed): Colloidal Drug Delivery Systems. New York, Dekker, 1994, vol 66: Drugs and the pharmaceutical sciences.
24. Lam AC, Schechter RS: The theory of diffusion in microemulsion. J Colloid Interface Sci 1987;120:56-63.
25. Denton MD, Magee CC, Sayegh MH: Immunosuppressive strategies in transplantation. Lancet 1999;353:1083-1091.
26. Kogan A, Garti N: Microemulsions as transdermal drug delivery vehicles. Adv Colloid Interface Sci 2006;123:369-385.
27. Ktistis G: A viscosity study on oil-in-water microemulsions. Int J Pharm 1990;61:213-218.
28. Alany RG, Tucker IG, Davies NM, Rades T: Characterizing colloidal structures of pseudoternary phase diagrams formed by oil/water/amphiphile systems. Drug Dev Ind Pharm 2001;27:31-38.
29. Podlogar F, Rogac MB, Gagperlin M: The effect of internal structure of selected water-Tween 40® Imwitor 308®-IPM microemulsions on ketoprofene release. Int J Pharm 2005;302:68-77.
30. Subramanian N, Ghosal SK, Acharya A, Moulik SP: Formulation and physicochemical characterization of microemulsion system using isopropyl myristate, mediumchain glyceride, polysorbate 80 and water. Chem Pharm Bull 2005;53:1530-1535.
31. Shukla A, Janich M, Jahn K, Krause A, Kiselev MA, Neubert RH: Investigation of pharmaceutical oil/water microemulsions by small-angle scattering. Pharm Res 2002;19:881-886.
32. Ruth HS, Attwood D, Ktistis G, Taylor CJ: Phase studies and particle size analysis of oil-in-water phospholipid microemulsions. Int J Pharm 1995;116:253-261.
33. Shukla A, Krause A, Neubert RHH: Microemulsions as colloidal vehicle systems for dermal drug delivery. IV. Investigation of microemulsion systems based on a eutectic mixture of lidocaine and prilocaine as the colloidal phase by dynamic light scattering. J Pharm Pharmacol 2003;55:741-748.
34. Attwood D, Ktistis G: A light-scattering study on oil-in-water microemulsions. Int J Pharm 1989;52:165-171.
35. Kreilgaard M, Pedersen EJ, Jaroszewski JW: NMR characterisation and transdermal drug delivery potential of microemulsion systems. J Control Release 2000;69:421-433.
36. Hua L, Weisan P, Jiayu L, Ying Z: Preparation, evaluation, and NMR characterization of vinpocetine microemulsion for transdermal delivery. Drug Dev Ind Pharm 2004;30:657-666.
37. Kumar P, Mittal KL (eds): Handbook of Microemulsion Science and Technology. New York, Dekker, 1999.
38. Mrestani Y, Neubert RHH, Krause A: Partition behaviour of drugs in microemulsions measured by electrokinetic chromatography. Pharm Res 1998;15:799-801.
39. Jahn W, Strey R: Microstructure of microemulsions by freeze-fracture electron microscopy. J Phys Chem 1988;92:2294-2301.
40. Vavra I, Machova A, Holecek V, Cort JH, Zaoral M, Sorm F: Effect of a synthetic analogue of vasopressin in animals and in patients with diabetes insipidus. Lancet 1968;1:948-952.
41. Getie M, Wohlrab J, Neubert RHH: Dermal delivery of desmopressin acetate using colloidal carrier systems. J Pharm Pharmacol 2005;57:423-427.
42. Rose EH, Aledort LM: Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease. Ann Intern Med 1991;114:563-568.
43. Gratz I, Koehler J, Olsen D, et al: The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. J Thorac Cardiovasc Surg 1992;104:1417-1422.
44. Cattaneo M, Tenconi PM, Alberca I, Garcia VV, Mannucci PM: Subcutaneous desmopressin (DDAVP) shortens the prolonged bleeding-time in patients with liver cirrhosis. Thromb Haemost 1990;64:358-360.
45. Miller K, Atkin B, Moody ML: Drug-therapy for nocturnal enuresis - Current treatment recommendations. Drugs 1992;44:47-56.
46. Shulman LH, Miller JL, Rose LI: Desmopressin for diabetes insipidus, hemostatic disorders and enuresis. Am Fam Physician 1990;42:1051-1057.
47. Getie M, Neubert RHH: LC-MS determination of desmopressin acetate in human skin samples. J Pharm Biomed Anal 2004;35:921-927.
48. Vilhardt H, Lundin S: Biological effect and plasma-concentrations of DDAVP after intranasal and peroral administration to humans. Gen Pharmacol 1986;17:481-483.
49. Tran HS, Malli D, Chrzanowski FA, Puc PM, Matthews MS, Hewitt CW: Site-specific immunosuppression using a new formulation of topical cyclosporine A with polyethylene glycol-8 glyceryl caprylate caprate. J Surg Res 1999;83:136-140.
50. Wohlrab J, Neubert R, Jahn K: Drug compositions containing cyclosporin and their application as topical systems. PCT/EP 02/053565.
51. Jahn K: Moderne galenische Zubereitungen zur dermalen Anwendung von Ciclosporin A und Mycophenolatmofetil; PhD thesis, Martin Luther University Halle-Wittenberg, Herzogenrath, Shaker, 2002.
52. Liu HZ, Li SM, Wang YJ, Han F, Dong Y: Bicontinuous water-AOT/Tween 85 isopropyl myristate microemulsion: a new vehicle for transdermal delivery of cyclosporin A. Drug Dev Ind Pharm 2006;32:549-557.
53. Alvarez-Figueroa MJ, Blanco-Mendez J: Transdermal delivery of methotrexate: iontophoretic delivery from hydrogels and passive delivery from microemulsions. Int J Pharm 2001;215:57-65.
54. Alvarez-Figueroa MJ, Delgado-Charro MB, Blanco-Mendez J: Passive and iontophoretic transdermal penetration of methotrexate. Int J Pharm 2001;212:101-107.